Marc van Dijk

2022

In 2022, Marc van Dijk earned a total compensation of $651.2K as Chief Scientific Officer at MiNK Therapeutics.

Compensation breakdown

Bonus$79,853
Option Awards$281,250
Salary$252,334
Other$37,737
Total$651,174

van Dijk received $281.3K in option awards, accounting for 43% of the total pay in 2022.

van Dijk also received $79.9K in bonus, $252.3K in salary and $37.7K in other compensation.

Rankings

In 2022, Marc van Dijk's compensation ranked 3,911th out of 5,736 executives tracked by ExecPay. In other words, van Dijk earned more than 31.8% of executives.

ClassificationRankingPercentile
All
3,911
out of 5,736
32nd
Division
Manufacturing
2,216
out of 3,125
29th
Major group
Chemicals And Allied Products
1,074
out of 1,416
24th
Industry group
Drugs
1,008
out of 1,317
24th
Industry
Biological Products, Except Diagnostic Substances
235
out of 291
19th
Source: SEC filing on April 29, 2024.

van Dijk's colleagues

We found two more compensation records of executives who worked with Marc van Dijk at MiNK Therapeutics in 2022.

2022

Jennifer Buell

MiNK Therapeutics

Chief Executive Officer

2022

Christine Klaskin

MiNK Therapeutics

Treasurer

News

You may also like